#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    X-linked lymphoproliferative syndrome Crigler-Najjar syndrome Familial haemophagocytic lymphohistiocytosis Osteomyelitis Hyperinsulinism Dedifferentiated liposarcoma Peritoneal mesothelioma malignant Haemophagocytic lymphohistiocytosis Kawasaki's disease Restless legs syndrome Von Hippel-Lindau disease Angiosarcoma Progressive supranuclear palsy Cytokine release syndrome Cutaneous T-cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Chronic granulomatous disease – Treatment SAPHO syndrome – Basic Information Haemophilia A without inhibitors – Trials in Disease Epidermolysis bullosa – Trials in Disease Familial haemophagocytic lymphohistiocytosis Lymphatic malformation – Diagnostics Immunodeficiency congenital – Trials in Disease Mucopolysaccharidosis II – Life with Disease Soft tissue sarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    AAV9-CTNT-COBAG3 GLYCYL-TYROSINE LY4170156 Mps-214 Lutikizumab Atenolol Adezunap Dmd06-Mab Zamtocabtagene Autoleucel Secukinumab ENSIFENTRINE Bidridistrogene Xeboparvovec Methotrexate Disodium Art6043 Ribonucleic Acid Medi0618 Mannitol Lolium Perenne Sulodexide Alternaria Alternata Extract More therapies…

    Learn about Your Condition

    Deafness neurosensory Angiosarcoma Onychomycosis Albright's disease Sleep disorder Pulmonary sarcoidosis Coronary artery occlusion Incontinence Abortion threatened Pancreatitis acute Laryngeal leukoplakia Ligament sprain Undifferentiated sarcoma Hypomagnesaemia Adenomatous polyposis coli More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of ION363 for Patients with Amyotrophic Lateral Sclerosis with Fused in Sarcoma Mutations

    Not recruiting

    4 1 1
    Investigated Diseases:
    • Amyotrophic lateral sclerosis
    Investigated Drugs:
    • ULEFNERSEN
    Belgium Germany Ireland Italy The Netherlands Poland +2

  • Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +12

  • Study on the Long-term Safety of Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Batoclimab
    Belgium Bulgaria Denmark Germany Greece Italy +4

  • Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

    Not recruiting

    2 1
    Investigated Drugs:
    • 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
    Czechia France Italy Poland Spain

  • Study on the Safety and Effects of ALN-APP for Patients with Cerebral Amyloid Angiopathy

    Not recruiting

    2 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    Investigated Drugs:
    • ALN-961583
    The Netherlands

  • Study on Diclofenac Potassium and Rimegepant for Treating Migraine in Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Migraine
    Investigated Drugs:
    • DICLOFENAC POTASSIUM
    • Rimegepant
    Denmark
Previous Page
1 … 89 90 91 92 93 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!